(CNN) – The Centers for Disease Control and Prevention at EE.UU. dialogue with United Kingdom health officials to obtain more information about British data suggesting that a new coronavirus variant could be more deadly.
“The CDC has communicated with the officials of the United Kingdom and is revising its new mortality dates associated with variant B.1.1.7”, said a CNC official of CNN on Saturday, using the scientific number of the variant that will be live for the first time in the United Kingdom in November.
A report from the United Kingdom published the four companies that there is “a realistic probability” that the new variant will have a mortality rate more than other variants.
If the dates are not clear, the British Prime Minister, Boris Johnson, says that “there is no evidence that the new variant … can be associated with a mayor’s degree of mortality”.
A statement from the Centers for Disease Control and Prevention will be held in Atlanta on December 10. Credit: Jason Armond / Los Angeles Times / Getty Images
Variant found in 22 EE states. UU.
The model of the CDC shows that this new variant, which has been demonstrated with special speed, can be converted to the predominant variant in the United States in March.
At the moment, only 195 cases of the new variant in EE.UU. have been detected, according to the CDC, but public health officials believe that many more cases are disappearing. There are 22 homes, indicating CDC, California and Florida, and it’s special to him.
Hasta now, the studies suggest that the current vacancies protect against the new variant and that the use of masks, the social distance and the hygiene of manos his claves to control the spread of the virus.
Michael Osterholm, epidemiologist and member of President Joe Biden’s Coronavirus Transmission Team, said he had revised the United Kingdom’s report, as well as other data that he has not seen publicly, and it is “convenient” that the new variant is more mortal.
“Aumentan dates, and some of them can not be shared, which clearly answer that the B.1.1.7 is causing more and more serious deaths,” said Osterholm, director of the Center for Infection Investigation at the University of Minnesota. “We know that this variant has increased the transmission, because it is a very small notice”.
An assessor of the CDC says that ideal series that medical doctors can examine and see how patients are treated with the new variant in comparison with infected patients with other variants.
Prohibition of probes, dr. William Schaffner, an expert in infectious diseases at the Vanderbilt University Medical Center, said that this could be difficult because of genomic sequencing – the necessary laboratory work to detect new diseases – is not a solid United.
“Our actual capacity to determine whether its patient in particular has this new cap is very limited, because it actually refutes the notion that other countries have much more capacity to make it than ours,” said Schaffner, member of the Assessment Committee the CDC on immunization practices.
The United Kingdom has one of the most solid genomic sequencing programs in the world. Brinda informs details of various studies that compare the pregnancy of the new variant with the previous ones.
The United Kingdom’s principal assessor, Patrick Vallance, cites mortality data and agrees that the evidence has not been solid and the data are becoming increasingly uncertain.
“If it’s empty … a man of 60 years, the huge drug is that for every 1,000 people infected, it will be estimated that approximately 10 people will be killed by the virus. With the new variant, for every 1,000 people infected, it is estimated that approximately 13 or 14 people will die, ”explained the four.
“This is the type of change for this type of edification, an increase of 10 to 13 or 14 of each 1,000 and will also be in the different editions groups of a type similar to the relative increase in risk”, aggregate
The analyzes quoted in the United Kingdom include the findings of the School of Hygiene and Tropical Medicine of London, the Imperial College of London, the University of Exeter and the Public Health of England.